These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 9153319)

  • 21. Triplex formation by psoralen-conjugated chimeric oligonucleoside methylphosphonates.
    Cassidy RA; Kondo NS; Miller PS
    Biochemistry; 2000 Jul; 39(29):8683-91. PubMed ID: 10913277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The high stability of the triple helices formed between short purine oligonucleotides and SIV/HIV-2 vpx genes is determined by the targeted DNA structure.
    Svinarchuk F; Monnot M; Merle A; Malvy C; Fermandjian S
    Nucleic Acids Res; 1995 Oct; 23(19):3831-6. PubMed ID: 7479024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting neighbouring poly(purine.pyrimidine) sequences located in the human bcr promoter by triplex-forming oligonucleotides.
    Xodo LE; Rathinavelan T; Quadrifoglio F; Manzini G; Yathindra N
    Eur J Biochem; 2001 Feb; 268(3):656-64. PubMed ID: 11168404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formation of stable DNA triple helices within the human bcr promoter at a critical oligopurine target interrupted in the middle by two adjacent pyrimidines.
    Xodo LE; Manzini G; Quadrifoglio F
    Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):477-88. PubMed ID: 9918112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of triple helix forming oligonucleotides to sites in gene promoters.
    Durland RH; Kessler DJ; Gunnell S; Duvic M; Pettitt BM; Hogan ME
    Biochemistry; 1991 Sep; 30(38):9246-55. PubMed ID: 1892832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyrimidine motif triplexes containing polypurine RNA or DNA with oligo 2'-O-methyl or DNA triplex forming oligonucleotides.
    Beban M; Miller PS
    Biochim Biophys Acta; 2000 Jun; 1492(1):155-62. PubMed ID: 10858542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short pyrimidine stretches containing mixed base PNAs are versatile tools to induce translation elongation arrest and truncated protein synthesis.
    Sénamaud-Beaufort C; Leforestier E; Saison-Behmoaras TE
    Oligonucleotides; 2003; 13(6):465-78. PubMed ID: 15025913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-linking to an interrupted polypurine sequence with a platinum-modified triplex-forming oligonucleotide.
    Campbell MA; Miller PS
    J Biol Inorg Chem; 2009 Aug; 14(6):873-81. PubMed ID: 19350290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triplex formation by morpholino oligodeoxyribonucleotides in the HER-2/neu promoter requires the pyrimidine motif.
    Basye J; Trent JO; Gao D; Ebbinghaus SW
    Nucleic Acids Res; 2001 Dec; 29(23):4873-80. PubMed ID: 11726697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities.
    Brunet E; Corgnali M; Perrouault L; Roig V; Asseline U; Sørensen MD; Babu BR; Wengel J; Giovannangeli C
    Nucleic Acids Res; 2005; 33(13):4223-34. PubMed ID: 16049028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of gene transcription by purine rich triplex forming oligodeoxyribonucleotides.
    Roy C
    Nucleic Acids Res; 1993 Jun; 21(12):2845-52. PubMed ID: 7687346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the intracellular stability and formation of a triple helix formed with a short purine oligonucleotide targeted to the murine c-pim-1 proto-oncogene promotor.
    Svinarchuk F; Debin A; Bertrand JR; Malvy C
    Nucleic Acids Res; 1996 Jan; 24(2):295-302. PubMed ID: 8628653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleosides and nucleotides. 218. Alternate-strand triple-helix formation by the 3'-3'-linked oligodeoxynucleotides using a purine motif.
    Hoshika S; Ueno Y; Matsuda A
    Bioconjug Chem; 2003; 14(3):607-13. PubMed ID: 12757386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triplex targeting of human PDGF-B (c-sis, proto-oncogene) promoter specifically inhibits factors binding and PDGF-B transcription.
    Liu J; Xu R; Jin Y; Wang D
    Nucleic Acids Res; 2001 Feb; 29(3):783-91. PubMed ID: 11160902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted cross-linking of the human beta-globin gene in living cells mediated by a triple helix forming oligonucleotide.
    Shahid KA; Majumdar A; Alam R; Liu ST; Kuan JY; Sui X; Cuenoud B; Glazer PM; Miller PS; Seidman MM
    Biochemistry; 2006 Feb; 45(6):1970-8. PubMed ID: 16460044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triple helix formation with purine-rich phosphorothioate-containing oligonucleotides covalently linked to an acridine derivative.
    Lacoste J; François JC; Hélène C
    Nucleic Acids Res; 1997 May; 25(10):1991-8. PubMed ID: 9115367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
    Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
    Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of nuclear protein binding to the human Ki-ras promoter by triplex-forming oligonucleotides.
    Mayfield C; Squibb M; Miller D
    Biochemistry; 1994 Mar; 33(11):3358-63. PubMed ID: 8136373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyamine effects on purine-purine-pyrimidine triple helix formation by phosphodiester and phosphorothioate oligodeoxyribonucleotides.
    Musso M; Van Dyke MW
    Nucleic Acids Res; 1995 Jun; 23(12):2320-7. PubMed ID: 7610062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodistribution and hepatic uptake of triplex-forming oligonucleotides against type alpha1(I) collagen gene promoter in normal and fibrotic rats.
    Cheng K; Ye Z; Guntaka RV; Mahato RI
    Mol Pharm; 2005; 2(3):206-17. PubMed ID: 15934781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.